Markets:

Overview

News

Currencies

International

Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

49.88 -3.36 (-6.31%)

Streaming Delayed Price Updated: 1:16 PM EDT, Sep 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

Final Deadline Reminder: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

April 18, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Today: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

April 18, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

PULSE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm

April 15, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)

April 15, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Deadline Monday Notice: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

April 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Pulse Biosciences, Inc. Announces Rights Offering

April 14, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Deadline Monday Reminder: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

April 14, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Monday Deadline Notice: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm

April 13, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

10 Health Care Stocks Whale Activity In Today's Session ↗

April 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

PLSE FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action - PLSE

April 09, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

April 07, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 07, 2022

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 07, 2022

We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today.

Via InvestorPlace

23 Stocks Moving in Thursday's Pre-Market Session ↗

April 07, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 46.7% to $1.88 in pre-market trading after the company announced it has harmonized its miRNA Whole Transcriptome...

Via Benzinga

PLSE INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

April 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

55 Biggest Movers From Friday ↗

April 04, 2022

Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49...

Via Benzinga

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE

April 02, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Mid-Afternoon Market Update: Nasdaq Turns Lower; Chicken Soup for the Soul Entertainment Shares Spike Higher ↗

April 01, 2022

U.S. stocks pared gains, with the Nasdaq Composite turning lower toward the end of trading on Friday.

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 01, 2022

Gainers Manning & Napier, Inc. (NYSE: MN) jumped 40.7% to $12.82 after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share....

Via Benzinga

Looking Into Pulse Biosciences's Return On Capital Employed ↗

April 01, 2022

Pulse Biosciences (NASDAQ:PLSE) brought in sales totaling $844.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 7.94%, resulting in a loss of $15.42...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

April 01, 2022

Wells Fargo lowered the price target on General Motors Company (NYSE: GM) from $83 to $72. GM shares rose 0.8% to $44.10 in pre-market trading.

Via Benzinga

Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results

March 31, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Outlook For Pulse Biosciences ↗

March 30, 2022

Pulse Biosciences (NASDAQ:PLSE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Pulse...

Via Benzinga

Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022

March 21, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

PLSE INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

March 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, A TOP RANKED FIRM, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLSE

March 11, 2022

WHY: New York, NY - (NewMediaWire) - March 11, 2022 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January...

Via NewMediaWire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action PLSE

March 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.